言語 |
英語
|
著者 |
Tomioka Haruaki
Department of Basic Medical Sciences for Nursing, Yasuda Women’s University, Hiroshima, Japan
Pieters Jean
Biozentrum, University of Basel, Basel, Switzerland
Tatano Yutaka
Department of Pharmaceutical Science, International University of Health and Welfare, Ohtawara, Japan
Kim Hyoji
Department of Microbiology, Faculty of Medicine, Shimane University, Izumo, Japan
|
主題 | eukaryotic-like serine/threonine kinase; PknG; macrophages; phagolysosome; anti-mycobacterial; chemotherapy
|
掲載誌名 |
FRONTIERS IN MICROBIOLOGY
|
巻 | 9
|
ISSN | 1664-302X
|
発行日 | 2018-07-12
|
DOI | |
PubMed ID | |
出版者 | FRONTIERS MEDIA SA
|
資料タイプ |
学術雑誌論文
|
部局 |
医学部
|
備考 | This study was supported by KAKENHI (Grant-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology (YK: 18K15168, HI: 18K07147, and HY: 16H05843 and 18K07148), GSK Japan Research Grant 2017 (YK), the Swiss National Science Foundation, the UBS Optimus Foundation, the Cantons of Basel (JP), and the Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare, Japan (HY and HI).
|